In addition, for specific patients with advanced NSCLC receiving immunotherapy, the levels of circ-0000190 and circ-0001649 were more relevant to immunotherapy efficiency than PD-L1 expression in the radiational assessment [143]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.